Effect of Different Sedation and Analgesia Strategies on Patients With Mechanical Ventilation
NCT ID: NCT05024799
Last Updated: 2021-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
300 participants
INTERVENTIONAL
2022-01-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sedation Protocols and Skeletal Muscle Metabolism in Mechanical Ventilated Patients
NCT03402113
Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)
NCT00479661
Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU.
NCT02122055
Safety and Efficacy of Combined Sedation With Midazolam and Dexmedetomidine in ICU Patients
NCT02080169
PK/PD of the Sedatives, Analgesics and Antibiotics in Patients Receiving ECMO
NCT03787550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
F-P group
the combination of fentanyl and propofol
Fentanyl, propofol
The patients in this group will be administered with fentanyl and propofol
F-D group
the combination of fentanyl and dexmedetomidine
fentanyl and dexmedetomindine
The patients in this group will be administered with fentanyl and dexmedetomindine
B-P group
the combination of butorphanol and propofol
Butorphanol and propofol
The patients in this group will be administered with butorphanol and propofol
B-D group
the combination of butorphanol and dexmedetomidine
Butorphanol and dexmedetomindine
The patients in this group will be administered with butorphanol and dexmedetomindine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fentanyl, propofol
The patients in this group will be administered with fentanyl and propofol
fentanyl and dexmedetomindine
The patients in this group will be administered with fentanyl and dexmedetomindine
Butorphanol and propofol
The patients in this group will be administered with butorphanol and propofol
Butorphanol and dexmedetomindine
The patients in this group will be administered with butorphanol and dexmedetomindine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Affiliated Hospital of Qingdao University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
JinyanXing
Director
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QYFYKYLL931311920
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.